April 10, 2021
Health News

FDA Hesitates On COVID Blood Plasma Treatment; Trump Isn’t Pleased : Coronavirus Live Updates – NPR

Convalescent serum or blood plasma from a recovered COVID-19 patients is being studied as a treatment for others with the disease. The FDA is holding off on giving it emergency use authorization.
Arnulfo Franco/AP
President Trump suggested in recent comments that there is a treatment for COVID-19 that members of his own administration are slow-walking to thwart his reelection bid.
The treatment is something called convalescent plasma. Since April, the Food and Drug Administration has been enc…

Click here to view the original article.

Related Posts

You might also like ...

Article feature image
Children are in the spotlight in the coronavirus battle – CBS News
Article feature image
Cancer-killing therapy using common cold virus may save patients with inoperable tumors – Study Finds
Article feature image
Dear Doctor: Should my wife and I avoid morning sex due to increased stroke risk? – OregonLive